(Q51631099)

8 April 2018

title

Effect of food intake on plasma levels and antihypertensive response during maintenance therapy with endralazine. (English)

1 reference

8 April 2018

author name string

J Kindler

1

1 reference

8 April 2018

P C Rüegg

2

1 reference

8 April 2018

M Neuray

3

1 reference

8 April 2018

W Pacha

4

1 reference

8 April 2018

publication date

1 January 1987

1 reference

8 April 2018

European Journal of Clinical Pharmacology

published in

1 reference

8 April 2018

volume

32

1 reference

8 April 2018

issue

4

1 reference

8 April 2018

page(s)

367-372

1 reference

8 April 2018

https://scigraph.springernature.com/pub.10.1007/bf00543971

exact match

0 references

cites work

Enhancement of the bioavailability of propranolol and metoprolol by food

1 reference

12 December 2020

Pharmacokinetics of orally administered furosemide

1 reference

12 December 2020

Sensitive high-performance liquid chromatographic assay for endralazine and two of its metabolites in human plasma

1 reference

12 December 2020

Gastrointestinal absorption of hydrochlorothiazide enhanced by concomitant intake of food

1 reference

12 December 2020

The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects

1 reference

12 December 2020

Hemodynamic study on a new antihypertensive drug (a pyridopyridazine) in the treatment of hypertensive crisis and resistent hypertension. First findings in man (author's transl)

1 reference

12 December 2020

Evaluation of once daily endralazine in hypertension

1 reference

12 December 2020

Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect

1 reference

12 December 2020

Hydralazine kinetics after single and repeated oral doses

1 reference

12 December 2020

[Management of treatment-resistant hypertension: comparison of the antihypertensive effect of endralazine and minoxidil (author's transl)]

1 reference

12 December 2020

Endralazine, a new peripheral vasodilator--a randomized cross-over trial against dihydralazine

1 reference

12 December 2020

Pharmacologic effects of the antihypertensive 6-benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine (BQ 22-708, endralazine)

1 reference

12 December 2020

Effects of meals on hemodynamics: implications for antihypertensive drug studies.

1 reference

12 December 2020

Clinical evaluation of endralazine (BO22708), a new vasodilator, in essential hypertension

1 reference

12 December 2020

Food-induced reduction in bioavailability of atenolol

1 reference

12 December 2020

Simplified method for determining acetylator phenotype.

1 reference

12 December 2020

Plasma concentration and acetylator phenotype determine response to oral hydralazine

1 reference

12 December 2020

Influence of acetylator phenotype on the pharmacokinetics of a new vasodilator antihypertensive, endralazine

1 reference

12 December 2020

Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake.

1 reference

12 December 2020

Effect of food on blood hydralazine levels and response in hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00543971

1 reference

8 April 2018

PubMed ID

3609114

1 reference

8 April 2018